A point mutation associated with leukocyte adhesion deficiency type 1 of moderate severity

AL Back, M Kerkering, D Baker, TR Bauer… - Biochemical and …, 1993 - Elsevier
AL Back, M Kerkering, D Baker, TR Bauer, LJ Embree, DD Hickstein
Biochemical and biophysical research communications, 1993Elsevier
Leukocyte adhesion deficiency (LAD) is a genetic disease characterized clinically by severe
bacterial infections, and biochemically by a deficiency in the surface expression of the CD
11/CD 18 leukocyte integrins. We studied a teenage girl with the moderate deficiency
phenotype of LAD. B-lymphoblastoid cells from this patient displayed approximately 5% of
normal levels of CD11/CD18 on the cell surface. Although a normal sized CD18 mRNA was
detectable on Northern blotting, a small CD18 protein was present on Western blotting …
Abstract
Leukocyte adhesion deficiency (LAD) is a genetic disease characterized clinically by severe bacterial infections, and biochemically by a deficiency in the surface expression of the CD 11/CD 18 leukocyte integrins. We studied a teenage girl with the moderate deficiency phenotype of LAD. B-lymphoblastoid cells from this patient displayed approximately 5% of normal levels of CD11/CD18 on the cell surface. Although a normal sized CD18 mRNA was detectable on Northern blotting, a small CD18 protein was present on Western blotting. Sequencing of the RNA revealed a single base pair substitution resulting in a glycine to serine amino acid substitution at amino acid 284. This amino acid substitution occurs within a highly conserved region of the extracellular domain of CD18 in which several other mutations have been identified in LAD.
Elsevier